Cargando…
Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease
Patients with chronic kidney disease (CKD) display an elevated risk of thrombosis. Thrombosis occurs in cardiovascular events, such as venous thromboembolism, stroke, and acute coronary syndrome, and is a cause of hemodialysis vascular access dysfunction. CKD leads to the accumulation of uremic toxi...
Autores principales: | Addi, Tawfik, Dou, Laetitia, Burtey, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215213/ https://www.ncbi.nlm.nih.gov/pubmed/30322010 http://dx.doi.org/10.3390/toxins10100412 |
Ejemplares similares
-
The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease
por: Sallée, Marion, et al.
Publicado: (2014) -
Food-Derived Uremic Toxins in Chronic Kidney Disease
por: Lauriola, Mara, et al.
Publicado: (2023) -
Protein/Fiber Index Modulates Uremic Toxin Concentrations in Hemodialysis Patients
por: Ebersolt, Manon, et al.
Publicado: (2022) -
What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022) -
The Therapeutic Strategies for Uremic Toxins Control in Chronic Kidney Disease
por: Lu, Ping-Hsun, et al.
Publicado: (2021)